[Chemotherapeutic studies on advanced tuberculosis in mice].
D000636:Aminosalicylic Acids / Q000008:administration & dosage; D000818:Animals; D000995:Antitubercular Agents / Q000008:administration & dosage* / Q000627:therapeutic use*; D004352:Drug Resistance, Microbial; D004357:Drug Synergism; D004977:Ethambutol / Q000008:administration & dosage; D005000:Ethionamide / Q000008:administration & dosage / Q000627:therapeutic use; D007538:Isoniazid / Q000008:administration & dosage / Q000627:therapeutic use; D007612:Kanamycin / Q000008:administration & dosage; D051379:Mice; D008954:Models, Biological; D010619:Phenazines / Q000008:administration & dosage; D011718:Pyrazinamide / Q000008:administration & dosage; D013307:Streptomycin / Q000627:therapeutic use; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*; D014756:Viomycin / Q000008:administration & dosage
D000636:Aminosalicylic Acids; D000995:Antitubercular Agents; D010619:Phenazines; D011718:Pyrazinamide; D007612:Kanamycin; D004977:Ethambutol; D005000:Ethionamide; D007538:Isoniazid; D013307:Streptomycin; D014756:Viomycin
Etudes chimiothérapiques sur la tuberculose avancée de la souris.